Ekr Therapeutics

Manufacturer of oncology based products and others generics

placeBedminster, New Jersey, United States calendar_todayFounded 2005 groups33 employees language ekrtx.com

Innovation

2 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 1,338 times.

YearFilings
20121
20131
20141
20151
20161
20171
20191
20201
20211
20231

Investor mix

6 investors on record; lead investors include LLR Partners, Quaker Partners Management; 2 have since exited.

Investor typeCountShare
Venture capital117%
Private equity350%
Bank & private debt117%
Other / undisclosed117%
Coming soon